Jack Rudd
Editorial Director, Analytical Cannabis
Jack has been working in science publishing since 2015 and has been the editorial lead of Analytical Cannabis since its launch in early 2017. He holds a 1st class Bachlor's in Biological Sciences from Essex University, where he received the distinguished Eliahou Dangoor scholarship for his work. He is also a member of ASTM Committee D37 on cannabis and attends a number of annual international cannabis science conferences. Prior to the launch of Analytical Cannabis, Jack worked in editorial for our parent publication, Technology Networks, where he focused on covering developments in cancer research, genomics, and informatics.
Latest content from Jack Rudd
Sources and Risks of 4 Common Cannabis Contaminants
This infographic looks at the sources and risks of a selection of contaminants of concern to cannabis producers and consumers alike.
Staying Ahead of the Curve in the Californian Cannabis Testing Industry
As tighter regulations mandate more rigorous testing, cannabis labs in California must plan and adapt to keep up with the huge influx of samples.
VIEW
Overcoming Technical Challenges in Cannabis Analysis
As the cannabis testing sector matures, attention continues to focus on enhancing analytical quality and meeting challenging new regulatory requirements.
VIEW
Trends in the Cannabis Testing Industry
As legalization spreads and regulators step in and tighten up testing requirements, labs in the sector must constantly adapt to keep up.
VIEW
Cannabinoids: Therapeutic Potential and Medical Uses
Explore the chemistry and state of research into the medical benefits of the major cannabinoids.
VIEW
15 Tips and Tricks for LC-MS Troubleshooting
This list will arm you with the basic knowledge required to effectively troubleshoot and solve common issues encountered with LC-MS analysis.
VIEW
Bringing Trusted Techniques and Technology to the Cannabis Testing Lab
Translating from fields like food and pharma to the cannabis testing sector is helping to provide medical patients and recreational consumers with safe thoroughly tested cannabis.
VIEW
Trends in Medical Cannabis: Epidiolex and the FDA
What does the recent FDA approval recommendation for Epidiolex mean for cannabis medicine? And, what's best, synthetic or natural cannabinoids? You can get answers in this Interview.
VIEW
Meet the Scientist: Dr Thomson and Her Path to the Cannabis Industry
Dr. Jaclyn Thomson, Director of R & D, Northern Vine Laboratories, explains how she first got interested in science and, what led her to working in the cannabis industry.
VIEW
Determining the Quality of High Purity Cannabidiol Isolates
As the demand for CBD-containing products soars around the world, determining the composition and purity of CBD isolates is vital for consumer safety and producers.
VIEW